← Back to Search

Measurement of Water in Breath and Saliva for Human Energy Expenditure

N/A
Waitlist Available
Led By Edward L Melanson, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will show if it's possible to measure the levels of 2H and 18O in saliva and breath, by comparing the natural abundances of these elements in saliva and urine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Natural abundances of 2H:1H and 18O:16O in humans

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy adults (18-45 yrs.)Experimental Treatment1 Intervention
Healthy adults (18-45 yrs.) will be recruited from the local Denver area. The investigators have elected to study a relatively homogenous sample to limit the impact of age, weight, and chronic disease on isotope fractionation in breath.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,730 Previous Clinical Trials
2,143,437 Total Patients Enrolled
2 Trials studying Human Energy Expenditure
107 Patients Enrolled for Human Energy Expenditure
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,350 Previous Clinical Trials
4,314,742 Total Patients Enrolled
1 Trials studying Human Energy Expenditure
72 Patients Enrolled for Human Energy Expenditure
Edward L Melanson, PhDPrincipal InvestigatorUniversity of Colorado, Denver
1 Previous Clinical Trials
72 Total Patients Enrolled
1 Trials studying Human Energy Expenditure
72 Patients Enrolled for Human Energy Expenditure

Media Library

Feasibility of measuring 2H:1H and 18O:16O in saliva and breath. Clinical Trial Eligibility Overview. Trial Name: NCT03233256 — N/A
Human Energy Expenditure Research Study Groups: Healthy adults (18-45 yrs.)
Human Energy Expenditure Clinical Trial 2023: Feasibility of measuring 2H:1H and 18O:16O in saliva and breath. Highlights & Side Effects. Trial Name: NCT03233256 — N/A
Feasibility of measuring 2H:1H and 18O:16O in saliva and breath. 2023 Treatment Timeline for Medical Study. Trial Name: NCT03233256 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any openings still available for this clinical trial?

"According to the data available on clinicaltrials.gov, this particular trial is not actively recruiting patients at present time. This research was initially posted in February 2018 and most recently updated in March 2022; however, there are still one other relevant studies inviting participants presently."

Answered by AI

Is eligibility for this trial open to me?

"This investigation is open to 60 individuals aged 18-45 who possess human energy expenditure. To be eligible, prospective patients must also fit the following criteria: male and female adults in good health between these ages."

Answered by AI

Does this medical research encompass individuals aged 45 or above?

"As documented in the trial's parameters, any patient over 18 years old and under 45 is eligible to participate."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Measurements of Water in Breath and Saliva
2018. "Measurements of Water in Breath and Saliva". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03233256.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top